Rixa Health does several things well — 48-state coverage, all-inclusive pricing, required monthly follow-ups, and no charge if you are disqualified before your visit. But it also lists retatrutide and "other peptides for weight loss" alongside semaglutide and tirzepatide, and that changes how you should read everything else on the site.
Overview
Rixa Health is a cash-pay telehealth service offering compounded weight loss medications across 48 states, with Alaska, Arkansas, Hawaii, North Dakota, and South Dakota listed as coming soon. Pricing is described as all-inclusive, covering the provider visit and medication with no hidden fees, and monthly follow-ups are required for the first six months.
The required follow-ups are a genuine positive — most cash-pay competitors make ongoing contact optional, and titration is exactly when clinical oversight matters. Rixa also states that if anything disqualifies you before the visit, you are notified and not charged, which is fairer than the no-refund policies some competitors publish.
The Retatrutide Problem
This needs to come before anything else, because it is the most consequential thing on the page.
Retatrutide is an investigational drug. It has not been approved by the FDA for weight management or any other indication. It is still in clinical development, which means its full safety profile, correct dosing, and long-term effects have not been established through completed regulatory review.
A compounded "retatrutide" sold direct to consumers is not the same category of product as compounded semaglutide. Compounded semaglutide at least copies a molecule with an approved reference product, established dosing, and a known safety profile. An investigational compound has none of that.
The same applies to unspecified "other peptides for weight loss." If a provider cannot tell you exactly what a substance is, whether it is FDA-approved, and what its established dosing is, that is not a treatment option — it is an experiment you are paying to be part of.
This materially lowers our rating. A provider willing to sell an unapproved investigational compound to consumers is telling you something about its risk tolerance that applies to the rest of its operation too. If you use Rixa, we would suggest confining yourself to semaglutide or tirzepatide and asking the provider directly why retatrutide is offered at all.
Rixa Health at a Glance
| Medications offered | Compounded semaglutide, compounded tirzepatide, oral semaglutide, oral tirzepatide, retatrutide, and other peptides for weight loss |
|---|---|
| Brand-name or compounded | Compounded. Retatrutide is investigational and not FDA-approved for any indication |
| Consultation process | Submit an intake form to confirm an appointment. During the visit the provider reviews your history, discusses goals, and develops a treatment plan |
| Eligibility | Not explicitly detailed beyond intake form submission. Rixa states you are notified and not charged if something disqualifies you before the visit |
| Provider involvement | Provider visit included in the price; monthly follow-ups are required for the first six months |
| Lab requirements | Not stated on the site |
| Pharmacy fulfillment | US partner pharmacies; specific partners are not named |
| Shipping frequency | Fast shipping stated; timeframes not published |
| Support services | 24/7 access stated; ongoing provider guidance included |
| Membership fees | None stated — the monthly plan price is all-inclusive |
| Medication fees | Not published. Rixa states the monthly plan is all-inclusive, covering the provider visit and medications with no hidden fees |
| Cancellation policy | A late-cancel or no-show fee applies; broader cancellation terms not stated |
| Refund policy | Not charged if disqualified before the visit; other refund terms not stated |
| Insurance | Not stated |
| HSA/FSA | Not stated |
| Availability | 48 states — Alaska, Arkansas, Hawaii, North Dakota, and South Dakota listed as coming soon |
Medications Offered
- Compounded semaglutide — injectable
- Compounded tirzepatide — injectable
- Oral semaglutide — compounded
- Oral tirzepatide — compounded
- Retatrutide — investigational, not FDA-approved
- Other peptides for weight loss — unspecified
Oral tirzepatide is worth a separate note. There is no FDA-approved oral tirzepatide product, so a compounded oral tirzepatide has no approved reference formulation and no established absorption data. That is a weaker evidence position than compounded oral semaglutide, which at least has approved oral semaglutide products to point at. See our tirzepatide guide.
Pricing and Fees
Rixa states its monthly plan is all-inclusive, covering the provider visit and medications with no hidden fees or additional costs. It does not publish the actual dollar amount.
All-inclusive is a good structure; unpublished is not. Bundling the visit into the medication price avoids the membership-stacking problem, but without a figure you cannot compare Rixa against Cora Health ($99–$175 all-inclusive) or Precision Telemed ($139.99). Get a written quote, and ask whether the price changes with dose or medication type.
One published fee: a late-cancel or no-show fee applies to appointments. Reasonable for a service with required monthly follow-ups, but know it exists.
Consultation and Eligibility
You submit an intake form, which confirms an appointment. If something disqualifies you, Rixa states you are notified before the visit and not charged. During the visit the provider reviews your history, discusses goals, and develops a treatment plan.
Not charging disqualified applicants is genuinely better than the alternative — Hello Alpha explicitly keeps its membership fee if your prior authorization is denied. Rixa also requires monthly follow-ups for the first six months, which is more clinical structure than most cash-pay programs impose.
Specific eligibility criteria and lab requirements are not published. Our eligibility guide covers what should be screened.
Pharmacy, Shipping, and Support
Rixa references US partner pharmacies with fast shipping and 24/7 access, but does not name the pharmacies or publish shipping timeframes. For compounded medication the pharmacy is the manufacturer, so this omission matters — and it matters more than usual here, given that some of the listed products have no approved reference formulation at all. See our storage and shipping guide.
The required monthly follow-ups for six months are the strongest part of the service. Providers that check in on a schedule catch titration problems that a ship-and-forget program misses entirely.
Cancellation, Refunds, Insurance, HSA/FSA
- Cancellation: a late-cancel or no-show fee applies to appointments. Broader plan cancellation terms are not published.
- Refunds: you are not charged if disqualified before the visit. Other refund terms are not stated.
- Insurance: not stated — treat as cash pay.
- HSA/FSA: not stated. See our HSA/FSA guide.
Pros and Cons
Pros
- Required monthly follow-ups for the first six months
- All-inclusive pricing structure with no separate membership
- Not charged if disqualified before the visit
- 48 states, with a published list of the exceptions
- Real provider visit rather than a form-only review
- Both injectable and oral formats offered
- 24/7 access stated
- Free shipping stated
Cons
- Lists retatrutide, an investigational non-FDA-approved drug
- Also lists unspecified "other peptides for weight loss"
- Oral tirzepatide has no approved reference formulation
- No prices published anywhere
- Pharmacy partners not named
- Eligibility criteria and lab requirements not published
- Broader cancellation terms not disclosed
- Late-cancel and no-show fees apply
- Insurance and HSA/FSA not addressed
- No FDA-approved brand-name option
Who Rixa Health May Be Best For
The genuine appeal here is the clinical structure: required monthly follow-ups for six months, a real provider visit, and no charge if you are disqualified. For someone who wants more oversight than a ship-and-forget program provides and lives in one of the 48 covered states, that is a real offer.
But we cannot recommend it over the alternatives while retatrutide and unspecified peptides sit on the menu. Cora Health covers all 50 states, publishes its prices, names its pharmacies, and sticks to semaglutide and tirzepatide. That is the same category of service without the regulatory question mark.
If you do use Rixa, stay with semaglutide or tirzepatide, and get the monthly price in writing first.
Limitations
This review is based on Rixa Health's published materials. Pricing, pharmacy partners, eligibility criteria, lab requirements, insurance, HSA/FSA, and broader cancellation terms are not disclosed. We have not verified shipping times, provider availability, or fulfillment quality. Our comments on retatrutide reflect its regulatory status as an investigational drug, and our comments on oral tirzepatide reflect the absence of an approved reference formulation — neither is a finding about the quality of any specific product Rixa dispenses.
Alternatives
- Same model, better disclosure: Cora Health — all 50 states, published prices, named pharmacies.
- Flat pricing and named pharmacies: Precision Telemed.
- Want FDA-approved medication: LillyDirect or NovoCare Pharmacy.
- Compare the field: best compounded GLP-1 providers.
Frequently Asked Questions
Is retatrutide legal to buy?
Retatrutide is an investigational drug that has not been approved by the FDA for any indication. Regardless of how it is marketed, buying a compounded version means taking a substance whose safety profile and correct dosing have not been established through completed regulatory review.
How much does Rixa Health cost?
Not published. Rixa states the monthly plan is all-inclusive, covering the provider visit and medications with no hidden fees. Request a written quote before booking.
Which states does Rixa serve?
48 states. Alaska, Arkansas, Hawaii, North Dakota, and South Dakota are listed as coming soon. Publishing the exceptions explicitly is better practice than vague "most states" language.
Does oral tirzepatide work?
There is no FDA-approved oral tirzepatide product, so a compounded oral version has no approved reference formulation and no established absorption data. Discuss expected outcomes with the prescribing provider rather than assuming equivalence to the injection.
What happens if I do not qualify?
Rixa states you are notified before the visit and not charged. That is fairer than providers that keep a membership fee regardless of outcome.
Medical Disclaimer & Review Date
This review is general consumer information, not medical advice. GLP-1 medications are prescription drugs with serious contraindications, and whether any treatment is appropriate for you is a decision only a licensed healthcare provider who knows your medical history can make. Nothing here should be used to start, stop, or change a medication.
Details in this review come from Rixa Health's own published materials as of the date below. Pricing, medication availability, state coverage, and policies in this category change frequently — verify current terms directly with the provider before purchasing.
Date reviewed: August 5, 2026
Stick to Molecules With Approved Reference Products
Compounded semaglutide and tirzepatide at least copy approved drugs with established dosing. Investigational compounds do not. Know which one you are buying.